NMC Specialty Hospital
9
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Utility of Defining ARDS and Past and Current Definitions of ARDS
Role: lead
How Well do we Feed the Critically Ill Patients
Role: lead
Intraoperative Hypocapnia in PROVHILO and PROBESE
Role: lead
Practice Variation on Antithrombotics in COVID-19
Role: lead
Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.
Role: lead
Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
Role: lead
Communication in ICU During COVID-19
Role: lead
Current Pharmacological Practices in Severe COVID-19
Role: lead
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
Role: lead
All 9 trials loaded